10.01.05
A new generation of joint supplements has been discovered by Hyben Vital, a Danish company, which produces a product called LitoZin. The rights for LitoZin have been secured by Europharma, Green Bay, WI, which will market the product in the U.S. market. Protected by both manufacturing and use patents, the product has been shown to be safe and clinically effective in 82% of patients with effects seen in as little as three weeks, according to the company. LitoZin contains a galactolipid compound called GOPO, which has anti-inflammatory properties. GOPO content varies considerably in different species of rose hip. But through years of analysis and development, Hyben Vital has been able to produce a unique sub-species of the rose hip plant with the highest content of GOPO.